Alimanio, Cj M.
HRN: 12-82-68 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/23/2022
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
05/23/2022
05/30/2022
PO
4ml
Bid
Age With Moderate Dhn, Uti
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes